Cargando…
Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
Local inflammation in axial spondyloarthritis (axSpA) leads to the release of collagen metabolites from the disease-affected tissue. We investigated whether collagen metabolites were associated with disease activity and could distinguish non-radiographic(nr)-axSpA from ankylosing spondylitis (AS). A...
Autores principales: | Hušáková, Markéta, Bay-Jensen, Anne-C., Forejtová, Šárka, Zegzulková, Kateřina, Tomčík, Michal, Gregová, Monika, Bubová, Kristýna, Hořínková, Jana, Gatterová, Jindra, Pavelka, Karel, Siebuhr, Anne Sofie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677742/ https://www.ncbi.nlm.nih.gov/pubmed/31375691 http://dx.doi.org/10.1038/s41598-019-47502-z |
Ejemplares similares
-
Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
por: Hušáková, Markéta, et al.
Publicado: (2020) -
Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort
por: Bubová, Kristyna, et al.
Publicado: (2019) -
Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis
por: Prajzlerová, Klára, et al.
Publicado: (2017) -
S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity
por: Šumová, Barbora, et al.
Publicado: (2020) -
Effect of group-based physiotherapy on pain and depression in patients with axial spondyloarthritis and non-specific low back pain: data of 1-year follow-up
por: Hušáková, Markéta, et al.
Publicado: (2023)